Skip to main content
Smart Investors Daily
Windtree Therapeutics, Inc. logo

NASDAQ · WINT

Windtree Therapeutics, Inc.

Healthcare · Biotechnology

$0.00

Up+$0.00 (+0.00%)

Updated Sep 19, 2026, 8:29 PM

SID Score

4.2/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
2.09M
P/E ratio
-0
Dividend yield
0.00%
52-week range
— – —
Volume
70K
Avg. volume
299.79K

Price performance

WINT price history

1M range · 0 trading sessions · Daily adjusted prices

WINT does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest WINT news

The latest Smart Investors Daily articles mentioning WINT.

WINT research

Overview

Company profile and research snapshot.

Company profile

WINDTREE THERAPEUTICS NEW

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
WINT recent ratings
DateFirmRatingTarget
Dec 4, 2024HC Wainwright & Co.Neutral
Jan 3, 2024HC Wainwright & Co.Neutral
Jun 4, 2021OppenheimerOutperform
Jun 26, 2020Ladenburg ThalmannBuy
Jun 30, 2017Stifel NicolausHold
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Mar 17, 2026

CommLoan Achieves Nationwide Regulatory Approval Across All 50 States

CommLoan, a commercial real estate lending technology company operating the first true AI-powered commercial mortgage lending marketplace, announced today that it has obtained the final approvals needed to operate and do business in all 50 states, without restriction.

globenewswire.com · Nov 13, 2025

Windtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company

Windtree and TESI signed a letter of intent for a combination of cash and securities of TESI to be paid to Windtree The companies were engaged in a potential environmental services deal for Windtree to acquire Titan Environmental Services, Inc. The executed agreement releases the parties from their reciprocal surviving obligations WARRINGTON, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on becoming a revenue generating company, announced that it has signed a letter of intent with TESI (OTC: TESI), an environmental services company, and Windtree will receive $7.5 million in cash and TESI securities.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.